ASA’s fortieth anniversary focuses on the human factor, by dedicating a full schedule of initiatives for its employees, to create moments of sharing in the name of the team. People, the main company asset, are the driving force that from 1983 to date has enabled the company to achieve significant milestones:

These figures are joined by prestigious collaborations (European Space Agency, Italian Space Agency, Federscherma – Fencing federation, Mobile Clinic, uncountable sports clubs and associations) and by excellence projects that have meant the company received international awards, both as concerns industrial design and product functionality.

Two new studies conducted by Jolien Robijns PhD (Hasselt University, Belgium) investigated and confirmed the efficacy of MLS^® Laser Therapy for the prevention of acute radiodermatitis in patients with breast cancer undergoing hypofractionated radiotherapy and on the long-time safety of the treatment for patients treated with standard fractionated radiotherapy. The key nature of the oncological issue is also confirmed by the webinar “Neuropathy and lymphoedema in oncology patients”, which follows the success of the first meeting on 21^st February.